Lena Ceballos is a biotech marketing and communications leader with nearly 15 years of experience, including 10 years of bench science. She manages corporate communications at Arcturus Therapeutics, where she helps with brand strategy, public engagement and creation of marketing materials to support the launch of the world’s first self-amplifying mRNA COVID-19 vaccine.
Ceballos blends scientific depth with creative strategy. She started her career in the lab, advancing into roles that shape media engagement and patient education. Ceballos earned her Bachelor of Science in biochemistry and cell biology from UC San Diego and a professional Master of Science in biotechnology management from the University of Maryland Global Campus.
Beyond her role at Arcturus, Ceballos helped establish 1STRAND, a grassroots biotech collective supporting RNA research, education and community science in San Diego. She also serves on the board of the Foundation for mRNA Medicine, advocating for the advancement of RNA therapeutics. She was recognized as a Rising Star at Fierce Pharma’s PR & Communications Summit. Ceballos mentors underrepresented biotech talent through Project Onramp and supports leadership equity through Lean In. Her work reflects the power of purpose-driven communication to advance and improve patient outcomes.
Ceballos helps lead communications, marketing and patient advocacy at Arcturus. She also assists with strategy and execution across a broad range of initiatives. Ceballos manages website development, SEO, social media and analytics while also producing visual media and branded film content to support scientific storytelling. Recently, she was formally assigned the full responsibility for the company’s patient advocacy program.